DEVELOPMENTAL FUNDS

项目总结(见说明)： 主任控制的发展资金来自机构来源，包括通过OHSU基金会筹集的奈特癌症研究所资金，OHSU医院和诊所以及医学院的捐款，以及我们CCSG的支持。局长有正式权力处理所有与癌症有关的事宜 OHSU基金会筹集的资金。奈特癌症研究所利用慈善来源的发展资金以及CCSG的支持来：招聘新的教员，支持试点项目，建立新的共享资源，并在共享资源内为技术和资源增强提供支持。在上一个资助期，OHSU的发展工作人员筹集了3300万美元的慈善捐款，另外还有9800万美元的捐赠将在未来5-7年内分发。此外，还设立了三个捐赠教员职位。 骑士使用CCSG资金，与慈善基金相匹配，支持试点项目、职业发展奖和过渡性资金。这种支持的目标一直是为癌症研究人员提供关键资源，以获得外部同行评审资金的初步资金，并鼓励创新的癌症研究项目。总计668,000美元的试点项目和职业发展奖 在过去的五年里，已经分配了资金。这些基金为2,090多万美元的外部同行审查资金作出了贡献。 发展基金已用于加强共享资源，并支持妇女参与临床试验。在过去的筹资期间，共享资源被大量投入，以扩大所提供的服务，升级仪器，并确保所提供的服务保持最先进的水平。为了支持妇女参与临床试验，将资金用于招聘专门研究女性的教员。 肿瘤学疾病和临床研究管理共享资源的基础设施支持。

PROJECT SUMMARY (See instructions): Developmental funds controlled by the Director are derive from institutional sources, including Knight Cancer Institute funds raised through the OHSU Foundation, contributions from the OHSU Hospital and Clinics and the School of Medicine, and the support from our CCSG. The Director has formal authority for all cancer related funds raised by the OHSU Foundation. The Knight Cancer Institute has used developmental funds from philanthropic sources as well as CCSG support to: recruit new faculty, support pilot projects, establish new Shared Resources, and provide support for technological and resource enhancements within the Shared Resources. In the last funding period, the OHSU development staff raised $33,000,000 in philanthropic contributions with an additional $98,000,000 gift that will be distributed over the next 5 - 7 years. Additionally, three endowed faculty positions have been established. The Knight has used CCSG funds, matched with philanthropic funds to support pilot projects, career development awards and bridge funding. The goal of this support has been to provide critical resources for cancer investigators to obtain preliminary funding for external peer-reviewed funding and to encourage innovative cancer research projects. A total of $668,000 of pilot project and career development award funding have been distributed over the past five years. These funds have contributed to over $20.9 million of external peer-reviewed funding. Development funds have been utilized to strengthen shared resources, as well as support women accruals to clinical trials. Over the past funding period shared resources have been invested in heavily to expand services offered, upgrade instrumentation, and ensure that sen/ices offered remain state-of-the art. To support accrual of women to clinical trials, funds were spent for recruitment of faculty specializing in female oncologic diseases, and infrastructure support for the Clinical Research Management Shared Resource.